These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A, Hill GS, Montseny JJ, Meyrier A. Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220 [Abstract] [Full Text] [Related]
3. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience. Lionaki S, Vlachopanos G, Georgalis A, Liapis G, Skalioti C, Zavos G, Boletis JN. Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638 [Abstract] [Full Text] [Related]
4. A clinicopathologic study of primary focal segmental glomerulosclerosis in children. Lanewala A, Mubarak M, Kazi JI, Akhter F, Sher A, Fayyaz A, Bhatti S. Saudi J Kidney Dis Transpl; 2012 May; 23(3):513-20. PubMed ID: 22569437 [Abstract] [Full Text] [Related]
6. [A case of collapsing variant of FSGS]. Nagai C, Yokota S, Kido Y, Katayama N, Nishiya M, Koizumi H, Namiki M, Nakamoto Y. Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):47-52. PubMed ID: 10771575 [Abstract] [Full Text] [Related]
7. Advanced therapeutics in focal and segmental glomerulosclerosis. Liu Y, Shi Y, Ren R, Xie J, Wang W, Chen N. Nephrology (Carlton); 2018 Oct; 23 Suppl 4():57-61. PubMed ID: 30298667 [Abstract] [Full Text] [Related]
8. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD. Transplantation; 2009 Apr 27; 87(8):1232-9. PubMed ID: 19384172 [Abstract] [Full Text] [Related]
9. [Primary focal segmental glomerulosclerosis in adults: response to treatment and outcome]. Niang A, Hachim K, Zahiri K, Fatihi E, Benghanem M, Ramdani B, Sqalli S, Zaid D. Dakar Med; 2004 Apr 27; 49(1):13-6. PubMed ID: 15782470 [Abstract] [Full Text] [Related]
10. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis. Chiou YY, Lee YC, Chen MJ. Curr Med Res Opin; 2017 Aug 27; 33(8):1389-1399. PubMed ID: 28436233 [Abstract] [Full Text] [Related]
11. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group. Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F. Turk J Pediatr; 2010 Aug 27; 52(3):255-61. PubMed ID: 20718182 [Abstract] [Full Text] [Related]
12. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A. Am J Kidney Dis; 1999 Oct 27; 34(4):618-25. PubMed ID: 10516340 [Abstract] [Full Text] [Related]
13. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. J Am Soc Nephrol; 2004 Aug 27; 15(8):2169-77. PubMed ID: 15284302 [Abstract] [Full Text] [Related]
14. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L. Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947 [Abstract] [Full Text] [Related]
15. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis. Wee Leng G, Mustafar R, Kamaruzaman L, Mohd R, Cader RA, Wei Yen K, Kiew Bing P. Acta Med Indones; 2018 Jul 15; 50(3):237-243. PubMed ID: 30333274 [Abstract] [Full Text] [Related]
16. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D. Nephrol Dial Transplant; 2004 Dec 15; 19(12):3062-7. PubMed ID: 15507477 [Abstract] [Full Text] [Related]
17. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study. Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB. Nephron Clin Pract; 2006 Dec 15; 104(2):c75-82. PubMed ID: 16785738 [Abstract] [Full Text] [Related]
18. Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults. Jafry N, Ahmed E, Mubarak M, Kazi J, Akhter F. Nephrol Dial Transplant; 2012 Mar 15; 27(3):1101-6. PubMed ID: 21804085 [Abstract] [Full Text] [Related]
19. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. Bhimma R, Adhikari M, Asharam K, Connolly C. Am J Nephrol; 2006 Mar 15; 26(6):544-51. PubMed ID: 17159342 [Abstract] [Full Text] [Related]
20. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis. Tumlin JA, Miller D, Near M, Selvaraj S, Hennigar R, Guasch A. Clin J Am Soc Nephrol; 2006 Jan 15; 1(1):109-16. PubMed ID: 17699197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]